ARCHIVES

Myriad In Partnership To Market Products.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981

Prime Contract Subcontract Opportunities

January 24, 1975

Letter to The Editor: IOM Panel Urges Greater Integration Of Research

February 12, 1999

NCI Announces Designation Of Comprehensive Center

July 20, 1990

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

In Brief: Simone Moves To huntsman Foundation, Golde Names MSK Physician-In-Chief

January 26, 1996